Welcome to our dedicated page for Claritev SEC filings (Ticker: MPLNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Claritev's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Claritev's regulatory disclosures and financial reporting.
Hellman & Friedman–affiliated funds filed Amendment No. 3 to Schedule 13D on Claritev Corporation (CTEV), reporting aggregate beneficial ownership of 3,887,858 shares, or 23.5% of Class A common stock. The percentage is based on 16,525,644 shares outstanding as of November 3, 2025.
The filing discloses a secondary sale by H&F selling stockholders of 1,500,000 shares at a $51.50 public offering price per share, less a $2.8325 underwriting discount, with an underwriters’ overallotment option for up to 225,000 shares. A 60‑day lock‑up from November 12, 2025 applies to the issuer, directors, officers, the H&F selling stockholders, and others, subject to exceptions.
If the overallotment is exercised, the filing notes beneficial ownership would be 3,662,858 shares, or 22.2%. The funds state investment intent and may buy or sell securities over time, subject to market conditions and agreements referenced.
Claritev Corporation disclosed that affiliates of Hellman & Friedman sold 1,500,000 shares of its Class A common stock in an underwritten secondary offering at $51.50 per share. The Company did not sell any shares and received no proceeds from this transaction.
The Selling Stockholders granted the underwriters a 30-day option to purchase up to 225,000 additional shares. Barclays Capital, Guggenheim Securities, and Wells Fargo Securities acted as joint bookrunners. The offering closed on November 14, 2025. The agreement includes customary representations, warranties, conditions, termination provisions, and indemnification.
Claritev Corporation reported Q3 2025 results with revenue of $245,959 thousand, up from $230,495 thousand a year ago. Operating income was $10,067 thousand versus an operating loss last year, while net loss narrowed to $69,753 thousand from $391,450 thousand. Net loss per share was $4.23, adjusted for the 1-for-40 reverse split.
For the first nine months, revenue reached $718,859 thousand versus $698,479 thousand, with operating income of $36,387 thousand and a net loss of $203,712 thousand. Year-to-date operating cash flow was $51,038 thousand. Cash and cash equivalents were $39,152 thousand, plus $11,493 thousand of restricted cash, as of September 30, 2025. Long-term debt (net) was $4,546,671 thousand and shareholders’ deficit was $101,835 thousand. The company completed a January 30, 2025 refinancing, established a $350,000 thousand revolving credit facility (with $70,000 thousand outstanding at quarter end), and recorded interest expense of $101,232 thousand in Q3.
Claritev Corporation furnished a Form 8-K to announce it issued a press release reporting financial results for the third quarter ended September 30, 2025. The press release is attached as Exhibit 99.1 and incorporated by reference.
The information under Item 2.02, including Exhibit 99.1, is furnished and not filed under the Exchange Act and is not subject to Section 18 liability. The filing also lists Exhibit 104 for the cover page Inline XBRL data.
Claritev Corporation renewed contracts with its ten largest clients during 2025, a group that represented approximately 70% of total 2024 revenues. The renewals include automatically renewing agreements that were each renewed for one year.
Excluding clients with automatic one-year renewals, these largest clients accounted for approximately 57% of 2024 revenues. Within this group, the weighted average contract term is greater than three years, excluding the one-year automatic renewals. Claritev highlights continued focus on affordability, transparency, and quality through technology and AI across its enterprise platform.
Claritev Corp (CTEV) insider filing: the SVP, Chief Growth Officer reported a Form 4 for an RSU vesting event on 10/14/2025. The filing shows 7,684 Class A shares were withheld to cover taxes (Code F) at $55.26 per share, a non‑open‑market transaction tied to restricted stock unit vesting. Following this tax withholding, the officer directly holds 107,891 Class A shares.